Evaluation of radiofluorinated carboximidamides as potential IDO-targeted PET tracers for cancer imaging.

about

Evaluation of radiofluorinated carboximidamides as potential IDO-targeted PET tracers for cancer imaging.

Item

http://www.wikidata.org/entity/Q41470807

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Evaluation of radiofluorinated ...... ET tracers for cancer imaging.

@en

type

Item

label

Evaluation of radiofluorinated ...... ET tracers for cancer imaging.

@en

prefLabel

Evaluation of radiofluorinated ...... ET tracers for cancer imaging.

@en

P1476

Evaluation of radiofluorinated ...... ET tracers for cancer imaging.

@en

P2093

Epifanio Ruiz

http://www.w3.org/2001/XMLSchema#string

Haibin Tian

http://www.w3.org/2001/XMLSchema#string

Mikalai M Budzevich

http://www.w3.org/2001/XMLSchema#string

Xia Xiao

http://www.w3.org/2001/XMLSchema#string

Xuan Huang

http://www.w3.org/2001/XMLSchema#string

Zhongjie Pan

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice

Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan

Trial watch: IDO inhibitors in cancer therapy

In vivo imaging of therapy-induced anti-cancer immune responses in humans.

Important Hydrogen Bond Networks in Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Design Revealed by Crystal Structures of Imidazoleisoindole Derivatives with IDO1

Inhibition of T cell proliferation by macrophage tryptophan catabolism

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

Research progress of indoleamine 2,3-dioxygenase inhibitors

The indoleamine-2,3-dioxygenase (IDO) inhibitor 1-methyl-D-tryptophan upregulates IDO1 in human cancer cells

Eosinophil granulocytes account for indoleamine 2,3-dioxygenase-mediated immune escape in human non-small cell lung cancer.

P304

46900-46914

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.14898

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Michael L Doligalski

P577

2017-01-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28159919

http://www.w3.org/2001/XMLSchema#string

P932

5564531

http://www.w3.org/2001/XMLSchema#string